Logo image of EFTR

EFFECTOR THERAPEUTICS INC (EFTR) Stock Analyst Ratings

USA - NASDAQ:EFTR - US28202V2079 - Common Stock

0.18 USD
-0.09 (-32.56%)
Last: 7/2/2024, 8:16:09 PM
0.155 USD
-0.02 (-13.89%)
After Hours: 7/2/2024, 8:16:09 PM
Buy % Consensus

85

ChartMill assigns a Buy % Consensus number of 85% to EFTR. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 11.22. This target is 6133.33% above the current price.
EFTR was analyzed by 8 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about EFTR.
In the previous month the buy percentage consensus was at a similar level.
EFTR was analyzed by 8 analysts. More opinions would make the average more meaningful.

Related screens

EFTR Historical Analyst RatingsEFTR Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -33 -30 -27 -24 -21 -18 -15 -12 -9 -6 -3 0 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 0.1810.1011.2211.2212.60 - 5,511.11% 6,133.33% 6,133.33% 6,900.00%

Related screens

EFTR Current Analyst RatingEFTR Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2024-03-28 HC Wainwright & Co. Reiterate Buy -> Buy
2024-02-06 HC Wainwright & Co. Maintains Buy -> Buy
2023-11-14 HC Wainwright & Co. Reiterate Buy -> Buy
2023-08-24 HC Wainwright & Co. Initiate Buy
2023-05-26 Stifel Upgrade Hold -> Buy
2023-05-10 Credit Suisse Maintains Outperform
2023-03-09 Credit Suisse Maintains Outperform
2023-01-09 JMP Securities Maintains Market Outperform
2023-01-06 Credit Suisse Maintains Outperform
2022-11-17 JMP Securities Maintains Market Outperform
2022-08-11 JMP Securities Maintains Market Outperform
2022-01-25 JMP Securities Maintains Market Outperform
2022-01-25 Stifel Downgrade Buy -> Hold
2022-01-25 Credit Suisse Maintains Outperform
2021-11-09 Stifel Upgrade Hold -> Buy
2021-10-12 Credit Suisse Initiate Outperform
2021-10-04 Mizuho Initiate Buy
2021-09-21 JMP Securities Initiate Market Outperform
2021-09-20 Stifel Initiate Hold
2021-09-13 Cantor Fitzgerald Initiate Overweight

EFFECTOR THERAPEUTICS INC / EFTR FAQ

What is the price target for EFTR stock?

8 analysts have analysed EFTR and the average price target is 11.22 USD. This implies a price increase of 6133.33% is expected in the next year compared to the current price of 0.18.


Can you provide the consensus rating for EFFECTOR THERAPEUTICS INC stock?

The consensus rating for EFFECTOR THERAPEUTICS INC (EFTR) is 85 / 100 . This indicates that analysts generally have a positive outlook on the stock.


How many analysts have analysed EFFECTOR THERAPEUTICS INC (EFTR)?

The number of analysts covering EFFECTOR THERAPEUTICS INC (EFTR) is 8.